ARCT: arcturusrx.com Expected earnings per share growth for next year

Public company logo of Arcturus Therapeutics (ARCT)

The complex transportation of mRNA drugs in cryocontainers requires significant cold chain expenditures. The projected EPS growth for next year confirms this trend, fixing the metric at -19.40. Stable cash flows and partner payments support Arcturus Therapeutics (ARCT), while its strong reputation for developing innovative vaccines ensures the trust of the medical community.

Arcturus Therapeutics Inc (ARCT): Net earnings per share change forecast for next year from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Arcturus Therapeutics Inc (ARCT)

Fundamental company valuation:ARCT, arcturusrx.com
Finished products of Arcturus Therapeutics Holdings Inc.

This indicator reflects the consensus forecast for the change in earnings per share, calculated as the difference between expected and current earnings. By analyzing the target growth rate of earnings per share, investors assess the probability of commercializing mRNA therapies for Arcturus Therapeutics (ARCT), where the chart's dynamics depend directly on clinical trial results and the prospects of government contracts.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Eton Pharma|KMDA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year fulcrumtx.com (FULC)|Expected earnings per share growth for next year Abeona Therapeutics Inc. ABEO|Earnings growth forecast for next year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Net earnings per share change forecast for next year|PLRX - Net earnings per share growth forecast for next year|APLT - Earnings growth forecast for next year|RNTX: Earnings growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year